- Home
- PAVM vs UG Comparison
PAVM vs UG Comparison
Compare PAVM & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | UG |
|---|---|---|
| Founded | 2014 | 1942 |
| Country | United States | United States |
| Employees | 41 | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1M | 36.5M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | PAVM | UG |
|---|---|---|
| Price | $5.11 | $7.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | 8.6K | ★ 9.3K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $10,545,468.00 |
| Revenue This Year | $603.94 | N/A |
| Revenue Next Year | $33.16 | N/A |
| P/E Ratio | ★ N/A | $36.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.21 | $5.58 |
| 52 Week High | $28.44 | $8.78 |
Technical Indicators
Market Signals| Indicator | PAVM | UG |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 47.84 |
| Support Level | $4.45 | $6.90 |
| Resistance Level | $6.56 | $7.49 |
| Average True Range (ATR) | 0.46 | 0.37 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 37.46 | 21.10 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
About UG United-Guardian Inc.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.